trending Market Intelligence /marketintelligence/en/news-insights/trending/vb_uxzjtxkrihvtz1zgg2g2 content esgSubNav
In This List

Shire increases maximum tender offer for Baxalta debt to $2.33B

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Shire increases maximum tender offer for Baxalta debt to $2.33B

Shire PLC said it increased the maximum tender amount of certain outstanding senior notes of its unit Baxalta to $2.33 billion from $2.25 billion.

Illinois-based Baxalta, Shire's wholly owned subsidiary, develops products for hemophilia, immunology and oncology.

Other terms and conditions for the tender offer remain unchanged, the Dublin-based biotechnology company said.

Citigroup Global Markets Ltd. and Morgan Stanley & Co. LLC are acting as dealer managers, with Global Bondholder Services Corp. acting as depository and information agent.